Comparative effectiveness of risk mitigation strategies to prevent fetal exposure to mycophenolate.

While the REMS programme achieved less pregnancies at treatment initiation, it failed to prevent the onset of pregnancy during treatment. Enhanced approaches to ensure effective contraception during treatment should be considered.